Company
BIOMARIN PHARMACEUTICAL INC
BMRN · CIK 0001048477
Acquisition (code A) of 6,140 shares at $0 per share.
Reporting Person Plenge Robert M · Transaction Code A
Traded Sep 10, 2026 · Disclosed Sep 14, 2026
Source: SEC Form 4 · 0001628280-26-061940 · filed 2026-09-14 · View filing →
Sale of 17,557 shares at $66.284 per share.
Reporting Person Davis George Eric · Officer Title EVP, Chief Legal Officer · Transaction Code S
Traded Sep 2, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001628280-26-060572 · filed 2026-09-03 · View filing →